Psilocybin for Obsessive-Compulsive Disorder (OCD) with Sorcha O'Connor, PhD(c)

Psilocybin for Obsessive-Compulsive Disorder (OCD) with Sorcha O'Connor, PhD(c)

Author: Lynn Marie Morski, MD, JD January 9, 2025 Duration: 35:33
Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
HealthHealth & FitnessFitnessMedicineMental

In this episode, Sorcha O'Connor, PhD(c) joins to discuss the research into the use of psilocybin to address obsessive-compulsive disorder (OCD). Sorcha is completing her neuroscience PhD at Imperial College London, specialising in mental health research. She led PsilOCD, a pioneering study investigating low-dose psilocybin as a treatment for both the clinical symptoms and cognitive features of OCD.

In this conversation, Sorcha introduces obsessive-compulsive disorder and discusses the ways medical professionals are currently thinking about this and other related conditions. She mentions that current therapies for OCD often only minimally improve symptoms, emphasizing the need for better treatment options. This led to studies exploring psilocybin as a treatment for OCD - and Sorcha emphasizes that the early trials have shown positive results, often with significant decreases in OCD symptoms. In conclusion, Sorcha discusses the protocol for the PsilOCD study at Imperial College London, with results from this study soon to be published.  

 

In this episode you'll hear:

  • The features of obsessive-compulsive disorder (OCD) 
  • The history and development of treatments for OCD
  • The theory behind the hypothesis that psilocybin may be effective for OCD
  • Trials exploring the efficacy of psychedelic treatments for OCD
  • Why psilocybin has come to the fore more than LSD or ketamine for prospective OCD studies
  • How patients are evaluated for OCD

 

Quotes:

"[OCD] is this complex behavioral pattern and certain medications moderately help and nothing seems to be highly effective yet and that definitely points to the need for novel pharmacotherapy."  [12:46]

"[By utilizing lower doses of psilocybin], people who maybe fixate on their health and on their mental health and sensations and things can benefit from psilocybin without having to overcome that barrier." [18:25]

 

Links:

Sorcha on LinkedIn

PsilOCD Study details on the Imperial College London website

Dr. Michael J. Greenberg's website

Psychedelic Medicine Association

Porangui

 


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 100

Official website RSS
instagramlinkedin
Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Microdosing Psilocybin: Truth vs Hype with Rotem Petranker, PhD [not-audio_url] [/not-audio_url]

Duration: 47:32
In this episode Rotem Petranker, PhD joins to discuss the current state of research on microdosing psilocybin. Dr. Petranker is the co-founder of the Psychedelic Studies Research Program at the University of Toronto and…
Encore Episode: Exploring Endogenous DMT with Rick Strassman, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode of the Psychedelic Medicine Podcast, Rick Strassman, MD joins to discuss the topic of endogenous DMT. Dr. Strassman is adjunct associate professor of psychiatry at the University of New Mexico in Albuquer…
Psychedelics for Stroke Healing with Steven Zeiler, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 32:57
In this episode Steven Zeiler, MD, PhD joins to discuss the promise of psychedelics for stroke healing. Dr. Zeiler is an associate professor and physician at Johns Hopkins School of Medicine specializing in cerebrovascul…
Long-Term Psychedelic Integration with J. Ashley T. Booth, LCSW, MS [not-audio_url] [/not-audio_url]

Duration: 34:40
In this episode J. Ashley T. Booth, LCSW, MS joins to discuss the importance of long-term psychedelic integration. Ashley is a Los Angeles-based psychedelic therapist, IFS practitioner, and author of Quieting the Storm W…
Is Psilocybin Safe for Me? with Seth Mehr, MD [not-audio_url] [/not-audio_url]

Duration: 52:41
In this episode, Seth Mehr, MD joins to share his expertise on safety planning prior to a patient undergoing psilocybin therapy. After a 20 year career as an Emergency Medicine physician, Seth founded Cascade Psychedelic…

«123456...10»